Prediabetes as a risk factor for all-cause and cause-specific mortality: a prospective analysis of 115,919 adults without diabetes in Mexico City (2024)

Advanced Search

Carlos A. Fermín-Martínez, Omar Yaxmehen Bello-Chavolla, César Daniel Paz-Cabrera, Daniel Ramírez-García, Jerónimo Perezalonso-Espinosa, Luisa Fernández-Chirino, Arsenio Vargas-Vázquez, Juan Pablo Díaz-Sánchez, Padme Nailea Méndez-Labra, Alejandra Núñez-Luna, Martín Roberto Basile-Alvarez, Paulina Sánchez-Castro, Fiona Bragg, Louisa Gnatiuc Friedrichs, Diego Aguilar-Ramírez, Jonathan R. Emberson, Jaime Berumen-Campos, Pablo Kuri-Morales, Roberto Tapia-Conyer, Jesus Alegre-Díaz, Jacqueline A. Seiglie, Neftali Eduardo Antonio-Villa

doi: https://doi.org/10.1101/2024.04.15.24305840

  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF

ABSTRACT

BACKGROUND Prediabetes has been associated with increased all-cause and cardiovascular mortality. However, no large-scale studies have been conducted in Mexico or Latin America examining these associations.

METHODS We analyzed data from 115,919 adults without diabetes (diagnosed or undiagnosed) aged 35-84 years who participated in the Mexico City Prospective Study between 1998 and 2004. Participants were followed until January 1st, 2021 for cause-specific mortality. We defined prediabetes according to the American Diabetes Association (ADA, HbA1c 5.7% to 6.4%) and the International Expert Committee (IEC, HbA1c 6.0-6.4%) definitions. Cox regression adjusted for confounders was used to estimate all-cause and cause-specific mortality rate ratios (RR) at ages 35-74 years associated with prediabetes.

FINDINGS During 2,085,392 person-years of follow-up (median in survivors 19 years), there were 6,810 deaths at ages 35-74, including 1,742 from cardiovascular disease, 892 from renal disease and 108 from acute diabetic crises. Of 110,405 participants aged 35-74 years at recruitment, 28,852 (26%) had ADA-defined prediabetes and 7,203 (7%) had IEC-defined prediabetes. Compared with those without prediabetes, individuals with prediabetes had higher risk of all-cause mortality at ages 35-74 years (RR 1.13, 95% CI 1.07-1.19 for ADA-defined prediabetes and RR 1.28, 1.18-1.39 for IEC-defined prediabetes), as well as increased risk of cardiovascular mortality (RR 1.22 [1.10-1.35] and 1.42 [1.22-1.65], respectively), renal mortality (RR 1.35 [1.08-1.68] and 1.69 [1.24-2.31], respectively), and death from an acute diabetic crisis (RR 2.63 [1.76-3.94] and 3.43 [2.09-5.62], respectively). RRs were larger at younger than at older ages, and similar for men compared to women. The absolute excess risk associated with ADA and IEC-defined prediabetes at ages 35-74 accounted for6% and 3% of cardiovascular deaths respectively, 10% and 5% of renal deaths respectively, and 31% and 14% of acute diabetic deaths respectively.

INTERPRETATION Prediabetes is a significant risk factor for all-cause, cardiovascular, renal, and acute diabetic deaths in Mexican adults. Identification and timely management of individuals with prediabetes for targeted risk reduction could contribute to reducing premature mortality from cardiometabolic causes in this population.

FUNDING Wellcome Trust, the Mexican Health Ministry, the National Council of Science and Technology for Mexico, Cancer Research UK, British Heart Foundation, UK Medical Research Council. Instituto Nacional de Geriatría (Mexico City).

Evidence before this study We conducted a literature search in PubMed to identify articles published in English before February 27th, 2024 that reported on prospective studies examining the association between prediabetes with all-cause or cause-specific mortality or progression to diabetes in a Mexican or Latin American population, using the terms (“prediabetes” OR “impaired fasting glucose” OR “impaired glucose tolerance”) AND (“mortality” OR “death”) AND (“Mexico” OR “Mexican” OR “Latin America” OR “Latin American”). There were no studies examining risk associated with prediabetes definitions and mortality among adults in Mexico. We identified one study from Peru that included 988 participants and investigated only all-cause mortality for impaired fasting glucose and HbA1c-based definitions of prediabetes from ADA and IEC; this study reported increased mortality risk related to ADA-defined prediabetes based on HbA1c measures. Generalizability of these findings to other Latin American countries and regions with distinct cardiometabolic profiles in unclear.

Added value of this study Our study included 115,919 participants without diabetes from Mexico City, of whom (26%) had ADA-defined prediabetes and 7,203 (7%) had IEC-defined prediabetes. We found that prediabetes is associated with higher risks of all-cause and cause-specific mortality (cardiovascular, renal, and acute diabetic causes) than among participants without prediabetes. We found RRs to be larger at younger than at older ages, and largely similar for men compared to women. Among those without previously diagnosed diabetes, we found that the excess risk associated with ADA- and IEC-defined prediabetes at ages 35-74 years accounted for 6% and 3% of cardiovascular deaths, 10% and 5% of renal deaths, and 31% and 14% of acute diabetic deaths, respectively. .

Implications of all the available evidence Our results show that prediabetes is a significant risk factor for cardiovascular, kidney, and acute diabetic deaths among Mexican adults and accounts for a notable fraction of such deaths. Identification of individuals with prediabetes should be prioritized for optimized management to improve cardiometabolic outcomes in Mexican adults.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research was also supported by Instituto Nacional de Geriatria in Mexico. The MCPS has received funding from the Wellcome Trust (058299/Z/99), the Mexican Health Ministry, the National Council of Science and Technology for Mexico, Cancer Research UK, British Heart Foundation, and the UK Medical Research Council (MC_UU_00017/2). The funding sources had no role in the design, conduct or analysis of the study or the decision to submit the manuscript for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by Ethics Committees at the Mexican Ministry of Health, the Mexican National Council for Science and Technology, and the University of Oxford, UK. All participants provided written informed consent.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

DATA AVAILABILITY

Data from the Mexico City Prospective Study are available to bona fide researchers. For more details, the study’s Data and Sample Sharing policy may be downloaded (in English or Spanish) from https://www.ctsu.ox.ac.uk/research/mcps. Available study data can be examined in detail through the study’s Data Showcase, available at https://datashare.ndph.ox.ac.uk/mexico/. Code is available for reproducibility of results at https://github.com/oyaxbell/prediabetes_mcps/.

Copyright

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Back to top

PreviousNext

PostedApril 16, 2024.

Download PDF

Supplementary Material

Data/Code

Email

Citation Tools

  • Facebook Like
  • Google Plus One

Subject Area

  • Endocrinology (including Diabetes Mellitus and Metabolic Disease)

Subject Areas

All Articles

  • Addiction Medicine (316)

  • Allergy and Immunology (621)

  • Anesthesia (162)

  • Cardiovascular Medicine (2298)

  • Dentistry and Oral Medicine (280)

  • Dermatology (202)

  • Emergency Medicine (371)

  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (819)

  • Epidemiology (11625)

  • Forensic Medicine (10)

  • Gastroenterology (683)

  • Genetic and Genomic Medicine (3629)

  • Geriatric Medicine (341)

  • Health Economics (622)

  • Health Informatics (2332)

  • Health Policy (919)

  • Health Systems and Quality Improvement (871)

  • Hematology (336)

  • HIV/AIDS (758)

  • Infectious Diseases (except HIV/AIDS) (13202)

  • Intensive Care and Critical Care Medicine (760)

  • Medical Education (361)

  • Medical Ethics (101)

  • Nephrology (394)

  • Neurology (3391)

  • Nursing (193)

  • Nutrition (512)

  • Obstetrics and Gynecology (654)

  • Occupational and Environmental Health (655)

  • Oncology (1777)

  • Ophthalmology (526)

  • Orthopedics (211)

  • Otolaryngology (284)

  • Pain Medicine (226)

  • Palliative Medicine (66)

  • Pathology (441)

  • Pediatrics (1014)

  • Pharmacology and Therapeutics (423)

  • Primary Care Research (410)

  • Psychiatry and Clinical Psychology (3104)

  • Public and Global Health (6022)

  • Radiology and Imaging (1238)

  • Rehabilitation Medicine and Physical Therapy (720)

  • Respiratory Medicine (814)

  • Rheumatology (370)

  • Sexual and Reproductive Health (359)

  • Sports Medicine (319)

  • Surgery (390)

  • Toxicology (50)

  • Transplantation (171)

  • Urology (143)

Prediabetes as a risk factor for all-cause and cause-specific mortality: a prospective analysis of 115,919 adults without diabetes in Mexico City (2024)
Top Articles
Latest Posts
Article information

Author: Msgr. Benton Quitzon

Last Updated:

Views: 6261

Rating: 4.2 / 5 (43 voted)

Reviews: 82% of readers found this page helpful

Author information

Name: Msgr. Benton Quitzon

Birthday: 2001-08-13

Address: 96487 Kris Cliff, Teresiafurt, WI 95201

Phone: +9418513585781

Job: Senior Designer

Hobby: Calligraphy, Rowing, Vacation, Geocaching, Web surfing, Electronics, Electronics

Introduction: My name is Msgr. Benton Quitzon, I am a comfortable, charming, thankful, happy, adventurous, handsome, precious person who loves writing and wants to share my knowledge and understanding with you.